ASPIRIN AND NOVEL ORAL ANTICOAGULANTS: REPORTING OF ADVERSE DRUG REACTIONS
5PSQ-106
FOCUSING AUDITS ON PATIENT SAFETY
5PSQ-105
EFFECTIVENESS AND TOXICITY PROFILE ANALYSIS OF ANTIFIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS
5PSQ-104
INVESTIGATING ERROR REPORTING RATES BY ALL PHARMACY STAFF IN THE PHARMACY DEPARTMENT OF A GENERAL HOSPITAL
5PSQ-103
PHARMACOLOGICAL STUDY OF HIV PATIENTS ENTERED INTO THE HOSPITAL
5PSQ-102
ANTIMICROBIAL TREATMENT INADEQUACY IN AN EMERGENCY DEPARTMENT
5PSQ-101
LESS-CHRON FOR DEPRESCRIBING IN NURSING HOME RESIDENTS
5PSQ-100
PUBLIC PERCEPTIONS AND CONCERNS INCLUDING MEDICATION AWARENESS IN LIFESTYLE HEALTH CAMPAIGNS
5PSQ-099
IMPACT OF ROBOTICS ON PATIENT SAFETY AND PRODUCTIVITY
5PSQ-098
USING A CUSTOMISED MEDICATION VERIFICATION TOOL ON ADMISSION TO HOSPITAL IN PSYCHIATRIC PATIENTS TO REDUCE CLINICALLY RELEVANT MEDICATION DISCREPANCIES
